Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of interest.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Semiparametric methods for evaluating the covariate-specific predictiveness of continuous markers in matched case-control studies.

Journal of the Royal Statistical Society. Series C, Applied statistics·2011
Same author

Comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929).

Statistics in medicine·2007
Same author

Evaluating technologies for classification and prediction in medicine.

Statistics in medicine·2005
Same author

Combining diagnostic test results to increase accuracy.

Biostatistics (Oxford, England)·2003
Same author

Comparing disease screening tests when true disease status is ascertained only for screen positives.

Biostatistics (Oxford, England)·2003
Same author

Phases of biomarker development for early detection of cancer.

Journal of the National Cancer Institute·2001
Same journal

Interim analysis in sequential multiple assignment randomized trials for survival outcomes.

Biometrics·2026
Same journal

Acknowledgment of Referees 2025.

Biometrics·2026
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
See all related articles

Related Experiment Video

Updated: Jun 23, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

A parametric ROC model-based approach for evaluating the predictiveness of continuous markers in case-control

Y Huang1, M S Pepe

  • 1Fred Hutchinson Cancer Research Center Public Health Sciences, 1100 Fairview Avenue N., Seattle, Washington 98109-1024, USA. yhuang@fhcrc.org

Biometrics
|May 23, 2009
PubMed
Summary
This summary is machine-generated.

This study introduces novel methods for estimating population risk stratification using case-control data, enhancing risk prediction model evaluation. These rank-invariant techniques improve the assessment of markers like prostate-specific antigen (PSA) for cancer risk prediction.

More Related Videos

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

Related Experiment Videos

Last Updated: Jun 23, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

Area of Science:

  • Biostatistics
  • Epidemiology
  • Medical Informatics

Background:

  • Predictiveness curves assess risk stratification by prediction models.
  • Existing inference methods use cross-sectional or cohort data.
  • Case-control studies are more common but underutilized for this analysis.

Purpose of the Study:

  • Develop methods for predictiveness curve inference using case-control studies.
  • Investigate the relationship between Receiver Operating Characteristic (ROC) curves and predictiveness curves.
  • Propose novel ROC-based methods for estimating predictiveness curves.

Main Methods:

  • Utilized case-control study data for inference.
  • Explored the mathematical relationship between ROC and predictiveness curves.
  • Developed rank-invariant ROC-based estimation methods.

Main Results:

  • Established alternative ROC interpretations for predictiveness curves.
  • Proposed ROC-based methods that are rank-invariant.
  • Demonstrated applicability to prostate-specific antigen (PSA) for prostate cancer risk.

Conclusions:

  • ROC-based methods offer advantages for predictiveness curve estimation from case-control data.
  • New methods are rank-invariant and can combine data across varying prevalence.
  • These advancements improve risk prediction model evaluation in common study designs.